| Short Description : | Recombinant-Active-Human ESM1-C-10*His protein was developed from mammalian cells and has a target region of C-10*His. For use in research applications. |
| Applications: | ELISA/WB |
| Host: | Mammalian Cells |
| Note: | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Conjugation: | Unconjugated |
| Dilution Range: | Reconstitute in sterile water for a stock solution. |
| Formulation: | Lyophilized from a solution in PBS pH 7.4, 5% Trehalose, 5% Mannitol. |
| Storage Instruction: | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at-20 to-80°C for twelve months from the date of receipt. |
| Endotoxin: | <0.1 EU/Mu g of the protein by the LAL method. |
| Immunoreactivity: | Measured by its ability of the Immobilised protein to support the adhesion of human acute T cell leukemia cells (Jurkat). When 1 x 10^5 cells/well are added to recombinant human ESM1 coated plates, adhesion is induced in a dose dependent manner after |
| Gene Symbol: | ESM1 |
| Gene ID: | 11082 |
| Uniprot ID: | ESM1_HUMAN |
| Immunogen: | Homo sapiens (Human) |
| Immunogen Region: | Trp20-Arg184 |
| Post Translational Modifications | May contain intrachain disulfide bonds. O-glycosylated.contains chondroitin sulfate and dermatan sulfate. |
| Function | Involved in angiogenesis.promotes angiogenic sprouting. May have potent implications in lung endothelial cell-leukocyte interactions. |
| Protein Name | Endothelial Cell-Specific Molecule 1Esm-1 |
| Database Links | |
| Cellular Localisation | Secreted |
| Alternative Protein Names | Endothelial Cell-Specific Molecule 1 proteinEsm-1 proteinESM1 protein |
Information sourced from Uniprot.org